Abstract:Aldehyde dehydrogenases (ALDHs) constitute a diverse superfamily of NAD(P)+-dependent enzymes pivotal in oxidizing endogenous and exogenous aldehydes to carboxylic acids. Beyond metabolic roles, ALDHs participate in essential biological processes, including differentiation, embryogenesis and the DNA damage response, while also serving as markers for cancer stem cells (CSCs). Aldehyde dehydrogenase 1B1 (ALDH1B1) is a mitochondrial enzyme involved in the detoxification of lipid peroxidation by-products and metabolism of various aldehyde substrates. This study examines the potential role of ALDH1B1 in human lung adenocarcinoma and its association with the CSC phenotype. To this end, we utilized the lung adenocarcinoma cell line A549, engineered to stably express the human ALDH1B1 protein tagged with green fluorescent protein (GFP). Overexpression of ALDH1B1 led to notable changes in cell morphology, proliferation rate and clonogenic efficiency. Furthermore, ALDH1B1-overexpressing A549 cells exhibited enhanced resistance to the chemotherapeutic agents etoposide and cisplatin. Additionally, ALDH1B1 overexpression correlated with increased migratory potential and epithelial–mesenchymal transition (EMT), mediated by the upregulation of transcription factors such as SNAI2, ZEB2 and TWIST1, alongside the downregulation of E-cadherin. Moreover, Spearman's rank correlation coefficient analysis using data from 507 publicly available lung adenocarcinoma clinical samples revealed a significant correlation between ALDH1B1 and various molecules implicated in CSC-related signaling pathways, including Wnt, Notch, hypoxia, Hedgehog, retinoic acid, Hippo, NF-κΒ, TGF-β, PI3K/PTEN-AKT and glycolysis/gluconeogenesis. These findings provide insights into the role of ALDH1B1 in lung tumor progression and its relation to the lung CSC phenotype, thereby offering potential therapeutic targets in the clinical management of lung adenocarcinoma.

Aldehyde Dehydrogenase 1A1 Up-Regulates Stem Cell Markers in Benzo[a]pyrene-Induced Malignant Transformation of BEAS-2B Cells.

Aldehyde Dehydrogenase 3A1 is Robustly Upregulated in Gastric Cancer Stem-Like Cells and Associated with Tumorigenesis.

Aldehyde Dehydrogenases and Cancer Stem Cells.

Aldh Maintains The Stemness Of Lung Adenoma Stem Cells By Suppressing The Notch/Cdk2/Ccne Pathway

Aldehyde dehydrogenase 1 is a tumor stem cell-Associated marker in lung cancer

MicroRNA Expression Profiling and the Role of ALCAM Modulating Tumor Growth and Metastasis in Benzo[a]pyrene-Transformed 16HBE Cells.

NOTCH-induced Aldehyde Dehydrogenase 1A1 Deacetylation Promotes Breast Cancer Stem Cells.

Clinicopathological Significance of ALDH1A1 in Lung, Colorectal, and Breast Cancers: a Meta-Analysis.

Exploring the Role and Pathophysiological Significance of Aldehyde Dehydrogenase 1B1 (ALDH1B1) in Human Lung Adenocarcinoma

Mir-377-3p-mediated EGR1 Downregulation Promotes B[a]P-Induced Lung Tumorigenesis by Wnt/Beta-Catenin Transduction

In Vitro Malignant Transformation of Human Bronchial Epithelial Cells Induced by Benzo(a)pyrene.

Prolonged exposure of environmental concentration benzo[ a ]pyrene promoted cancer stemness through AhR/PKA/SOX2 dependent pathway in small cell lung cancer

ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage

ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Expression Of Aldh1 And Tgf Beta 2 In Benign And Malignant Breast Tumors And Their Prognostic Implications

Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming

ALDH1 is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome.

Benzo(a)pyrene Regulated A549 Cell Migration, Invasion and Epithelial-Mesenchymal Transition by Up-Regulating Long Non-Coding RNA Linc00673

RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell lines

ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.